Literature DB >> 21683724

Abnormal sense of intention preceding voluntary movement in patients with psychogenic tremor.

Mark J Edwards1, Giovanna Moretto, Petra Schwingenschuh, Petra Katschnig, Kailash P Bhatia, Patrick Haggard.   

Abstract

Psychogenic tremor is the commonest psychogenic movement disorder, yet little is known of its pathophysiology. Given the presence of movements that appear from their physiological properties to be voluntarily produced, and yet are not experienced as such by the patients, we hypothesised that patients might have an abnormal conscious experience of volition with regard to self-generated movement. Nine patients with psychogenic tremor were asked to judge the timing of a self-paced button press relative to a clock displayed on a computer screen. In separate trials they were asked to judge the timing of their internal feeling of intention to move. These results were compared to those of healthy control participants. Patients with psychogenic tremor judged their feeling of intention to move significantly later compared to control participants. As a result, the interval between the perceived time of intention and the perceived time of action, which was highly significant in the control participants, was numerically smaller and non-significant in the patients. This study provides novel data that the sense of volition prior to movement is impaired in patients with psychogenic tremor. This fits with a pathophysiological explanation for this disorder based on an impairment of neural mechanisms that generate the conscious experience of action: actions that are voluntary in terms of their physiological origin might be experienced as involuntary.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21683724     DOI: 10.1016/j.neuropsychologia.2011.05.021

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  29 in total

Review 1.  Functional neurological disorders: mechanisms and treatment.

Authors:  Alexander Lehn; Jeannette Gelauff; Ingrid Hoeritzauer; Lea Ludwig; Laura McWhirter; Stevie Williams; Paula Gardiner; Alan Carson; Jon Stone
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

Review 2.  Functional (psychogenic) movement disorders.

Authors:  Kathrin Czarnecki; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

3.  Modulating conscious movement intention by noninvasive brain stimulation and the underlying neural mechanisms.

Authors:  Zachary H Douglas; Brian Maniscalco; Mark Hallett; Eric M Wassermann; Biyu J He
Journal:  J Neurosci       Date:  2015-05-06       Impact factor: 6.167

Review 4.  Neurology of volition.

Authors:  Sarah M Kranick; Mark Hallett
Journal:  Exp Brain Res       Date:  2013-01-18       Impact factor: 1.972

Review 5.  [Clinical and cognitive aspects of functional (psychogenic) tremor].

Authors:  K E Zeuner; R Schmidt; P Schwingenschuh
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 6.  Psychogenic movement disorders.

Authors:  Francesca Morgante; Mark J Edwards; Alberto J Espay
Journal:  Continuum (Minneap Minn)       Date:  2013-10

7.  Retraining and control therapy for pediatric psychogenic non-epileptic seizures.

Authors:  Aaron D Fobian; Dustin M Long; Jerzy P Szaflarski
Journal:  Ann Clin Transl Neurol       Date:  2020-08-03       Impact factor: 4.511

8.  Response inhibition in motor conversion disorder.

Authors:  Valerie Voon; Vindhya Ekanayake; Edythe Wiggs; Sarah Kranick; Rezvan Ameli; Neil A Harrison; Mark Hallett
Journal:  Mov Disord       Date:  2013-04-02       Impact factor: 10.338

9.  Impaired self-agency in functional movement disorders: A resting-state fMRI study.

Authors:  Carine W Maurer; Kathrin LaFaver; Rezvan Ameli; Steven A Epstein; Mark Hallett; Silvina G Horovitz
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

Review 10.  Volition and Action in the Human Brain: Processes, Pathologies, and Reasons.

Authors:  Itzhak Fried; Patrick Haggard; Biyu J He; Aaron Schurger
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.